With Roivant, Montes Archimedes May Have First SPAC-on-SPAC Deal

Montes Archimedes (NASDAQ:MAAC) announced its $5 billion business combination with Roivant Sciences on May 3, but some language in its 94-slide presentation has turned some heads two weeks after the fact with the realization that it sets up a potentially unprecedented SPAC situation. On slide 34, Roivant noted that it plans to enter into discussions
Read More